全文获取类型
收费全文 | 810篇 |
免费 | 25篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 24篇 |
妇产科学 | 12篇 |
基础医学 | 85篇 |
口腔科学 | 26篇 |
临床医学 | 90篇 |
内科学 | 132篇 |
皮肤病学 | 1篇 |
神经病学 | 71篇 |
特种医学 | 38篇 |
外科学 | 159篇 |
综合类 | 6篇 |
预防医学 | 69篇 |
眼科学 | 13篇 |
药学 | 65篇 |
中国医学 | 1篇 |
肿瘤学 | 42篇 |
出版年
2023年 | 6篇 |
2022年 | 16篇 |
2021年 | 22篇 |
2020年 | 20篇 |
2019年 | 18篇 |
2018年 | 23篇 |
2017年 | 16篇 |
2016年 | 14篇 |
2015年 | 19篇 |
2014年 | 38篇 |
2013年 | 47篇 |
2012年 | 82篇 |
2011年 | 67篇 |
2010年 | 30篇 |
2009年 | 23篇 |
2008年 | 46篇 |
2007年 | 59篇 |
2006年 | 38篇 |
2005年 | 43篇 |
2004年 | 32篇 |
2003年 | 35篇 |
2002年 | 31篇 |
2001年 | 9篇 |
2000年 | 10篇 |
1999年 | 4篇 |
1998年 | 2篇 |
1997年 | 4篇 |
1996年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
1993年 | 4篇 |
1992年 | 6篇 |
1991年 | 8篇 |
1990年 | 7篇 |
1989年 | 6篇 |
1988年 | 7篇 |
1987年 | 7篇 |
1986年 | 4篇 |
1985年 | 1篇 |
1984年 | 5篇 |
1983年 | 2篇 |
1982年 | 5篇 |
1980年 | 3篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1974年 | 1篇 |
1973年 | 2篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1970年 | 1篇 |
排序方式: 共有836条查询结果,搜索用时 15 毫秒
101.
102.
103.
Rink M Ehdaie B Cha EK Green DA Karakiewicz PI Babjuk M Margulis V Raman JD Svatek RS Fajkovic H Lee RK Novara G Hansen J Daneshmand S Lotan Y Kassouf W Fritsche HM Pycha A Fisch M Scherr DS Shariat SF;for the Bladder Cancer Research Consortium 《European urology》2012,62(4):677-684
BACKGROUND: Dissimilarities in management and outcomes exist between upper tract urothelial carcinoma (UTUC) and urothelial carcinoma of the bladder (UCB). OBJECTIVE: The aim of this study was to analyze the stage-specific impact of upper or lower urinary tract tumor location on oncologic outcomes. DESIGN, SETTING, AND PARTICIPANTS: Data were collected from 4335 patients with UCB treated with radical cystectomy (RC) and bilateral pelvic lymphadenectomy (PLND), 877 patients with ureteral UTUC, and 1615 with pelvicalyceal UTUC treated with radical nephroureterectomy (RNU). No patient received preoperative chemotherapy or radiation therapy. INTERVENTIONS: Patients were treated with RC and bilateral PLND or RNU. MEASUREMENTS: Outcomes were assessed according to primary tumor location. RESULTS AND LIMITATIONS: Compared to UTUC patients, UCB patients had more advanced tumor stage and higher grade, and they were more likely to harbor lymphovascular invasion (LVI) and lymph node metastasis (p<0.001). In non-muscle-invasive tumor stages, UCB patients were more likely to experience disease recurrence and mortality compared to renal pelvicalyceal tumor patients (p<0.002) but not ureteral tumors (p>0.05). In pT2 and pT3 tumors, there was no difference in outcomes between the three tumor locations. In pT4 tumors, patients with ureteral and pelvicalyceal tumors were more likely to experience disease recurrence and mortality compared to UCB patients (p<0.004). These stage-specific findings were unchanged after adjustment for the effects of age, gender, tumor grade, LVI, lymph node status, and adjuvant chemotherapy. This study is limited by its retrospective and multicenter nature. CONCLUSIONS: Stage-specific differences in outcomes exist between UCB and UTUC. The differentially worse outcomes by stage between UCB and UTUC patients underline the differences between both cancer entities and the need for individualized stage-specific management for each patient. 相似文献
104.
Shariat SF Zigeuner R Rink M Margulis V Hansen J Kikuchi E Kassouf W Raman JD Remzi M Koppie TM Bensalah K Guo CC Mikami S Sircar K Ng CK Haitel A Kabbani W Chun FK Wood CG Scherr DS Karakiewicz PI Langner C 《European urology》2012,62(2):224-231
Background
The clinical course of pT3 upper tract urothelial carcinoma (UTUC) is highly variable.Objectives
The aim of the current study was to validate the clinical and prognostic importance of pT3 subclassification in the renal pelvicalyceal system in a large international cohort of patients.Design, setting, and participants
From a multi-institutional international database, 858 renal pelvicalyceal tumors treated with radical nephroureterectomy (RNU) were systematically reevaluated by genitourinary pathologists. Category pT3 pelvic tumors were categorized as pT3a (infiltration of the renal parenchyma on a microscopic level only) versus pT3b (macroscopic infiltration of the renal parenchyma and/or infiltration of peripelvic adipose tissue).Intervention
RNU.Measurements
Associations of pT3 subclassifications with clinicopathologic features were assessed with the chi-square test. Prognostic impact was assessed with the log-rank test and multivariable Cox regression analyses.Results and limitations
Of 858 patients with renal pelvicalyceal tumors, 266 (31%) had pT3 disease. Of these, 146 (54.9%) were classified as pT3a and 120 (45.1%) as pT3b. Compared with pT3a, pT3b cancers were associated with higher tumor grade, nodal disease, and tumor necrosis. Ten-year recurrence-free (pT3a 58% vs pT3b 38%; p < 0.001) and cancer-specific (pT3a 60% vs pT3b 39%; p = 0.002) survival rates were lower for patients with pT3b disease. In multivariable analyses, classification pT3b was an independent predictor of both disease recurrence (hazard ratio [HR]: 1.8, p = 0.003) and cancer-specific mortality (HR: 1.7; p = 0.02). The major limitation is the retrospective character of the study.Conclusions
Subclassification of pT3 renal pelvicalyceal UTUC helps identify patients who are at increased risk of disease progression and cancer-related death. Further research may help assess the value of subclassification and its inclusion in future editions of the American Joint Committee on Cancer–International Union Against Cancer TNM classification system. 相似文献105.
106.
Amir S. Jadidi Hubert Cochet Ashok J. Shah Steven J. Kim Edward Duncan Shinsuke Miyazaki Maxime Sermesant Heiko Lehrmann Matthieu Lederlin Nick Linton Andrei Forclaz Isabelle Nault Lena Rivard Matthew Wright Xingpeng Liu Daniel Scherr Stephen B. Wilton Laurent Roten Patrizio Pascale Nicolas Derval Frédéric Sacher Sebastien Knecht Cornelius Keyl Mélèze Hocini Michel Montaudon Francois Laurent Michel Haïssaguerre Pierre Jaïs 《Journal of the American College of Cardiology》2013
107.
Marjo Berkhout Kristina Bengtsson Bostrm Anna-Lena
stberg 《Scandinavian journal of primary health care》2022,40(3):395
ObjectiveThis study explored the considerations and experiences of Swedish General Practitioners (GPs) of hypertension treatment in patients 80 years and above.DesignQualitative design with focus group interviews. Data were analysed by qualitative content analysis.SettingPrimary health care centres (PHCCs), both rural and urban, in the Region of Västra Götaland, Sweden.SubjectsGPs and GP trainees working at PHCCs in 2019 and 2020. Five focus group interviews with 24 physicians were performed.Main outcome measuresConsiderations and experiences of hypertension treatment in the oldest-old.ResultsEighteen GPs and six GP trainees participated in the study. The latent content was formulated in a theme: ‘The physician’s decision-making in the treatment of hypertension in the oldest-old implies the inclusion of both medical and humanistic considerations.’ The manifest content constituted three main categories: ‘The patient characteristics’ included medical condition, behavioural factors and daily life. ‘The physician’s role’ described the GP as a professional and her/his experienced support. ‘The treatment decision’ considered these categories and involved risk-benefit balancing and communication. For the future, the participants proposed better guidelines for the oldest-old multimorbid patients, increased teamwork, continuous cooperation with nurses and better cooperation with hospital physicians.ConclusionHypertension care for the oldest-old was experienced as complicated by GPs, due to the need of balancing medical and humanistic considerations. The GP’s clinical experience and the received support were of importance when making the treatment decision based on risk-benefit balancing and communication with the patient.
Key points
- GPs experienced the task of caring for the oldest-old patients with hypertension as complicated.
- Patient factors like multimorbidity, polypharmacy, behavioural factors and the patient’s condition of daily life were identified.
- Clinical experience and the experienced support at the PHCC were discussed as important for the GPs’ treatment decision.
- Treatment decisions for the oldest-old patients with hypertension were based on risk-benefit balancing and communication with the patients.
108.
Natascha Schweighofer Christoph W. Haudum Olivia Trummer Alice Lind Ewald Kolesnik Ines Mursic Albrecht Schmidt Daniel Scherr Andreas Zirlik Thomas R. Pieber Nicolas Verheyen Barbara Obermayer-Pietsch 《Nutrients》2022,14(24)
Sarcopenia is linked with an increased risk of falls, osteoporosis and mortality and is an increasing problem for healthcare systems. No satisfying biomarkers for sarcopenia diagnosis exist, connecting bone, fat and muscle. Matrix-GLA-protein (MGP) is an adipokine that regulates bone metabolism and is associated with decreased muscle strength. Associations of dp-ucMGP were analyzed in the BioPersMed cohort (58 ± 9 years), including 1022 asymptomatic subjects at moderate cardiovascular risk. Serum measurements of dp-ucMGP in 760 persons were performed with the InaKtif MGP Kit with the IDS-iSYS Multi-Discipline Automated System. DXA data (792 persons) measured with the Lunar iDXA system and physical performance data (786 persons) were available. Dp-ucMGP plasma levels correlate with sarcopenia parameters like gait speed (ρ = −0.192, p < 0.001), appendicular skeletal muscle mass (ρ = 0.102, p = 0.005) and appendicular skeletal muscle mass index (ρ = 0.112, p = 0.001). They are lower in persons with sarcopenia (p < 0.001) and higher in persons with reduced physical performance (p = 0.019). Persons in the lowest dp-ucMGP quartile have the highest risk for reduced muscle mass, decreasing with each quartile, whereas persons in the highest quartile have the highest risk of reduced muscle strength. Dp-ucMGP might be a good biomarker candidate in sarcopenia characterization. 相似文献
109.
Alexander Buerle Anna-Lena Frewer Vanessa Rentrop Lynik Chantal Schüren Marco Niedergethmann Julia Lortz Eva-Maria Skoda Martin Teufel 《Nutrients》2022,14(9)
Overweight and obesity carry a tremendous burden in terms of physiological and psychological comorbidities. There is a great variety of weight management applications to support weight reduction, but a systematical analysis of individuals’ needs and requirements to adopt sustaining lifestyle changes is missing so far. This study aimed to assess the acceptance of such applications and its underlying predictors in individuals with overweight/obesity. A cross-sectional study was conducted, including 439 overweight/obese individuals. Health-related internet use and acceptance of weight management applications were examined using a modified questionnaire based on the Unified Theory of Acceptance and Use of Technology (UTAUT). The general acceptance of weight management applications was high, with significant age differences. Compared to older individuals, younger ones showed a higher acceptance. BMI was not significantly associated with acceptance. Besides psychometric data and eHealth-related data, performance expectancy, effort expectancy, and social influence proved to be significant predictors for acceptance. The total variance explanation provided by the extended UTAUT model was 61.2%. The knowledge of the influencing factors on acceptance might be useful in developing, optimizing, and establishing weight management applications. For determining acceptance and its predictors of weight management applications, the UTAUT model is a valid approach. 相似文献
110.